PRESS RELEASE published on 06/05/2024 at 07:30, 1 year 11 months ago OSE Immunotherapeutics and Nantes University Hospital Present Positive Phase 1/2 Study Evaluating FR104/VEL-101 Immunotherapy in Renal Transplant OSE Immunotherapeutics and Nantes University Hospital present positive Phase 1/2 study evaluating FR104/VEL-101 immunotherapy in renal transplant at American Transplant Congress 2024 Immunotherapy Phase 1/2 Study OSE Immunotherapeutics Nantes University Hospital Renal Transplant
PRESS RELEASE published on 06/05/2024 at 07:00, 1 year 11 months ago Holcim advances circular construction with acquisition of Land Recovery in the UK Holcim strengthens circular construction capabilities with acquisition of Land Recovery in the UK, enhancing access to recycled construction materials and driving circular building solutions Acquisition Holcim Recycled Materials Land Recovery Circular Construction
PRESS RELEASE published on 06/05/2024 at 07:00, 1 year 11 months ago Informations privilégiées / Autres communiqués Valerio Therapeutics a tenu son assemblée générale mixte avec succès, adoptant toutes les résolutions du Conseil d'Administration. La Société se spécialise dans le développement de médicaments innovants ciblant les mécanismes de réponse aux dommages de l’ADN tumoral et les oncogènes pilotes Biotechnologie Assemblée Générale Cancer Valerio Therapeutics ADN Tumoral
PRESS RELEASE published on 06/05/2024 at 07:00, 1 year 11 months ago Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update Valneva announces availability of documentation for its Combined Shareholder Meeting on June 26, 2024, along with corporate update including change in General Counsel & Corporate Secretary. Kendra Wergin appointed as successor Corporate Update Valneva General Counsel Shareholder Meeting Kendra Wergin
PRESS RELEASE published on 06/05/2024 at 07:00, 1 year 11 months ago Inside Information / Other news releases Valerio Therapeutics reports successful Combined General Meeting with 48.1% quorum, adopting all resolutions. Consolidated vote results and meeting minutes to be available on the Company's website Euronext Growth Paris Biotechnology General Meeting Valerio Therapeutics DDR Drugs
PRESS RELEASE published on 06/05/2024 at 07:00, 1 year 11 months ago Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte et une évolution de son équipe de direction Valneva annonce la mise à disposition des documents préparatoires à son Assemblée Générale Mixte et une évolution de son équipe de direction Documents Préparatoires Valneva Assemblée Générale Mixte Équipe De Direction Kendra Wergin
PRESS RELEASE published on 06/05/2024 at 06:55, 1 year 11 months ago Leclanché SA: Invitation to the Upcoming Annual General Meeting of Shareholders to Be Held on 27 June 2024 at 10:00 am Swiss Time
PRESS RELEASE published on 06/05/2024 at 06:55, 1 year 11 months ago Leclanché SA: Invitation à la prochaine assemblée générale annuelle des actionnaires qui se tiendra le 27 juin 2024 à 10h00 (heure suisse)
PRESS RELEASE published on 06/05/2024 at 06:30, 1 year 11 months ago Avolta and utu Unleash 25% More Spending Power at Milan Airports with VAT Refund Innovation Avolta and utu launch a pilot programme in Milan airports to increase VAT refund value by 25%, enhancing duty-free shopping opportunities. The innovative programme aims to boost airside Duty-free revenue growth Avolta Duty-Free Shopping Utu VAT Refund Milan Airports
PRESS RELEASE published on 06/05/2024 at 06:23, 1 year 11 months ago Clearances received for the Joint Venture between Metall Zug and Miele Clearances received for the Joint Venture between Metall Zug and Miele. Closing planned on June 7, 2024, with operational activities to start soon after Joint Venture Operational Activities Metall Zug AG Miele Clearances Received
Published on 05/16/2026 at 01:15, 17 hours 1 minute ago Findev Inc. Announces a New Member of the Board of Directors
Published on 05/16/2026 at 00:00, 18 hours 16 minutes ago Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
Published on 05/15/2026 at 23:10, 19 hours 6 minutes ago Golden Minerals Reports First Quarter 2026 Financial Results
Published on 05/15/2026 at 23:00, 19 hours 16 minutes ago Jericho Energy Ventures Announces Transition to Semi-Annual Reporting to Enhance Efficiency
Published on 05/16/2026 at 16:08, 2 hours 8 minutes ago The publication of the audited financial statements for 2025 will be postponed to 12 June 2026 – management does not expect any significant changes to the figures already published
Published on 05/15/2026 at 20:10, 22 hours 6 minutes ago CPIPG Communication Concerning Voluntary Offer on NEXT RE Shares – Provisional Results Announcement
Published on 05/15/2026 at 18:10, 1 day ago Virtual Science AI launches first AI-driven competitor activity tracking platform to support pharma asset launch success
Published on 05/15/2026 at 15:08, 1 day 3 hours ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010203026
Published on 05/15/2026 at 15:00, 1 day 3 hours ago Exercice de l’option de remboursement de l'instrument subordonné FR0010203026
Published on 05/15/2026 at 10:09, 1 day 8 hours ago Groupe Crit : Modalités de mise à disposition des documents préparatoires à l’Assemblée Générale Mixte du 05 juin 2026.
Published on 05/14/2026 at 09:03, 2 days 9 hours ago Coup d'envoi pour les carrières dans l'esport : 65% de la population mondiale réclame plus de formations et de parcours professionnels pour le jeu vidéo de compétition
Published on 05/13/2026 at 18:02, 3 days ago ALTAREA : Assemblée Générale Mixte du 4 juin 2026 MODALITES DE MISE A DISPOSITION DES DOCUMENTS PREPARATOIRES